Intra-Cellular Therapies IncNASDAQ:ITCI
- LAST PRICE66.5650
- TODAY'S CHANGE (%)-1.9250 (-2.8106%)
- Bid / Lots66.5300/ 1
- Ask / Lots66.6000/ 4
- Open / Previous Close68.3800 / 68.4900
- Day Range
- 52 Week Range
- Volume1,034,865
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ITCI |
|---|---|---|
| 09:32 ET | 11587 | 68.36 |
| 09:34 ET | 3824 | 68.405 |
| 09:36 ET | 5831 | 69.44 |
| 09:38 ET | 15953 | 68.88 |
| 09:39 ET | 5818 | 69.59 |
| 09:41 ET | 4844 | 69.665 |
| 09:43 ET | 4035 | 69.75 |
| 09:45 ET | 5218 | 69.785 |
| 09:48 ET | 2731 | 69.975 |
| 09:50 ET | 12654 | 70.77 |
| 09:52 ET | 8965 | 71.105 |
| 09:54 ET | 5944 | 71.855 |
| 09:56 ET | 6951 | 71.3 |
| 09:57 ET | 9995 | 70.9225 |
| 09:59 ET | 1877 | 70.935 |
| 10:01 ET | 3200 | 70.58 |
| 10:03 ET | 1700 | 70.445 |
| 10:06 ET | 4061 | 70.85 |
| 10:08 ET | 9108 | 70.2 |
| 10:10 ET | 7661 | 70.09 |
| 10:12 ET | 5728 | 69.84 |
| 10:14 ET | 4209 | 69.8725 |
| 10:15 ET | 5865 | 69.9 |
| 10:17 ET | 3880 | 70.19 |
| 10:19 ET | 27122 | 70.06 |
| 10:21 ET | 7255 | 70.11 |
| 10:24 ET | 3850 | 70.115 |
| 10:26 ET | 10663 | 69.78 |
| 10:28 ET | 3934 | 69.61 |
| 10:30 ET | 6312 | 69.35 |
| 10:32 ET | 9560 | 69.585 |
| 10:33 ET | 2580 | 69.65 |
| 10:35 ET | 7643 | 69.42 |
| 10:37 ET | 4268 | 68.99 |
| 10:39 ET | 5728 | 68.99 |
| 10:42 ET | 9112 | 68.545 |
| 10:44 ET | 16263 | 68.355 |
| 10:46 ET | 3199 | 68.375 |
| 10:48 ET | 4180 | 68.505 |
| 10:50 ET | 6015 | 68.35 |
| 10:51 ET | 1759 | 68.58 |
| 10:53 ET | 2100 | 68.575 |
| 10:55 ET | 3725 | 68.31 |
| 10:57 ET | 5023 | 68.29 |
| 11:00 ET | 15834 | 68.06 |
| 11:02 ET | 7093 | 68.025 |
| 11:04 ET | 8406 | 68.07 |
| 11:06 ET | 7771 | 68.4 |
| 11:08 ET | 4167 | 68.295 |
| 11:09 ET | 1334 | 68.305 |
| 11:11 ET | 4380 | 68.3 |
| 11:13 ET | 2967 | 68.3 |
| 11:15 ET | 4666 | 67.95 |
| 11:18 ET | 3800 | 68.06 |
| 11:20 ET | 800 | 68.09 |
| 11:22 ET | 5865 | 67.86 |
| 11:24 ET | 3459 | 67.61 |
| 11:26 ET | 6224 | 68.2 |
| 11:27 ET | 1990 | 68.185 |
| 11:29 ET | 1700 | 68.09 |
| 11:31 ET | 2346 | 67.9 |
| 11:33 ET | 1300 | 67.98 |
| 11:36 ET | 48579 | 67.61 |
| 11:38 ET | 3273 | 67.675 |
| 11:40 ET | 900 | 67.69 |
| 11:42 ET | 5387 | 67.65 |
| 11:44 ET | 2171 | 67.705 |
| 11:45 ET | 2649 | 67.565 |
| 11:47 ET | 3754 | 67.72 |
| 11:49 ET | 200 | 67.655 |
| 11:51 ET | 1200 | 67.615 |
| 11:54 ET | 700 | 67.575 |
| 11:56 ET | 4350 | 67.4 |
| 11:58 ET | 2685 | 67.435 |
| 12:00 ET | 5523 | 67.4 |
| 12:02 ET | 1572 | 67.335 |
| 12:03 ET | 906 | 67.345 |
| 12:05 ET | 700 | 67.35 |
| 12:07 ET | 200 | 67.275 |
| 12:09 ET | 967 | 67.22 |
| 12:12 ET | 805 | 67.22 |
| 12:14 ET | 418 | 67.26 |
| 12:16 ET | 900 | 67.12 |
| 12:18 ET | 7724 | 67.345 |
| 12:20 ET | 800 | 67.305 |
| 12:23 ET | 1150 | 67.25 |
| 12:25 ET | 500 | 67.3 |
| 12:27 ET | 3300 | 67.2 |
| 12:30 ET | 1812 | 67.37 |
| 12:34 ET | 100 | 67.315 |
| 12:36 ET | 893 | 67.32 |
| 12:38 ET | 400 | 67.315 |
| 12:39 ET | 5094 | 67.02 |
| 12:41 ET | 3400 | 67.02 |
| 12:43 ET | 4368 | 67.1 |
| 12:45 ET | 2000 | 67.16 |
| 12:48 ET | 200 | 67.14 |
| 12:50 ET | 2719 | 67.1 |
| 12:52 ET | 14063 | 66.935 |
| 12:56 ET | 1084 | 66.87 |
| 12:57 ET | 1500 | 66.85 |
| 12:59 ET | 2905 | 66.93 |
| 01:01 ET | 824 | 66.8 |
| 01:03 ET | 1395 | 66.775 |
| 01:06 ET | 5403 | 66.755 |
| 01:08 ET | 16007 | 66.97 |
| 01:10 ET | 1961 | 66.965 |
| 01:12 ET | 2200 | 66.97 |
| 01:14 ET | 400 | 66.905 |
| 01:15 ET | 448 | 66.89 |
| 01:17 ET | 2017 | 67.005 |
| 01:19 ET | 1555 | 66.91 |
| 01:21 ET | 1000 | 66.84 |
| 01:24 ET | 4700 | 66.72 |
| 01:26 ET | 953 | 66.73 |
| 01:28 ET | 7672 | 66.66 |
| 01:30 ET | 1208 | 66.63 |
| 01:32 ET | 4097 | 66.8 |
| 01:33 ET | 1939 | 66.735 |
| 01:35 ET | 800 | 66.65 |
| 01:37 ET | 100 | 66.76 |
| 01:39 ET | 2937 | 66.905 |
| 01:42 ET | 1063 | 66.815 |
| 01:44 ET | 211 | 66.8195 |
| 01:46 ET | 920 | 66.83 |
| 01:48 ET | 1100 | 66.705 |
| 01:50 ET | 800 | 66.675 |
| 01:51 ET | 1000 | 66.65 |
| 01:53 ET | 4335 | 66.5 |
| 01:55 ET | 400 | 66.51 |
| 01:57 ET | 3772 | 66.54 |
| 02:00 ET | 13710 | 66.54 |
| 02:02 ET | 2394 | 66.51 |
| 02:04 ET | 676 | 66.51 |
| 02:06 ET | 600 | 66.51 |
| 02:08 ET | 3578 | 66.51 |
| 02:09 ET | 2100 | 66.54 |
| 02:11 ET | 1500 | 66.705 |
| 02:13 ET | 11722 | 66.26 |
| 02:15 ET | 30146 | 66.42 |
| 02:18 ET | 2524 | 66.635 |
| 02:20 ET | 1610 | 66.52 |
| 02:22 ET | 7904 | 66.53 |
| 02:24 ET | 7854 | 66.63 |
| 02:26 ET | 2134 | 66.765 |
| 02:27 ET | 800 | 66.785 |
| 02:29 ET | 5711 | 66.68 |
| 02:31 ET | 2300 | 66.705 |
| 02:33 ET | 2567 | 66.76 |
| 02:36 ET | 2881 | 66.8 |
| 02:38 ET | 1100 | 66.775 |
| 02:40 ET | 1167 | 66.76 |
| 02:42 ET | 2318 | 66.74 |
| 02:44 ET | 2401 | 66.565 |
Jun 25, 2024
DJ Intra-Cellular Therapies Cut to Neutral From Buy by UBS, from 12:25PM ET on Tuesday Jun 25, 2024 by Dow Jones
12:25PM ET on Tuesday Jun 25, 2024 by Dow JonesDJ Intra-Cellular Therapies Price Target Maintained With a $103.00/Share by RBC Capital, from 10:19AM ET on Tuesday Jun 25, 2024 by Dow Jones
10:19AM ET on Tuesday Jun 25, 2024 by Dow Jones
Jun 21, 2024
DJ Intra-Cellular Therapies Is Maintained at Buy by Mizuho, from 7:40AM ET on Friday Jun 21, 2024 by Dow Jones
7:40AM ET on Friday Jun 21, 2024 by Dow Jones
Jun 20, 2024
DJ Intra-Cellular Therapies Is Maintained at Buy by Canaccord Genuity, from 12:42PM ET on Thursday Jun 20, 2024 by Dow Jones
12:42PM ET on Thursday Jun 20, 2024 by Dow Jones
Jun 18, 2024
DJ Intra-Cellular Therapies Is Maintained at Buy by Needham, from 12:54PM ET on Tuesday Jun 18, 2024 by Dow Jones
12:54PM ET on Tuesday Jun 18, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Intra-Cellular Therapies Inc | 7.2B | -57.8x | --- |
Blueprint Medicines Corp | 6.7B | -22.6x | --- |
Tempus AI Inc | 5.8B | -18.3x | --- |
Legend Biotech Corp | 8.1B | -17.5x | --- |
Ascendis Pharma A/S | 7.9B | -14.3x | --- |
Ionis Pharmaceuticals Inc | 7.0B | -17.4x | --- |
Company Information
Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders. The Company leverages intracellular approach to develop treatments for people living with complex psychiatric and neurologic diseases. The Company’s product, CAPLYTA (lumateperone), is an oral, once daily atypical antipsychotic approved in adults for the treatment of schizophrenia and the treatment of depressive episodes associated with bipolar I or II disorder (bipolar depression) as monotherapy and as adjunctive therapy with lithium or valproate. Its pipeline includes several product candidates in clinical development and additional product candidates in non-clinical testing, such as ITI-1284-ODT-SL program, Phosphodiesterase type I inhibitor (PDE1) program, ITI-333 program, and ITI-1500 Non-Hallucinogenic Psychedelic program. ITI-1284 is a deuterated form of lumateperone, a new chemical entity.
Contact Information
- Headquarters
- 430 East 29th Street, Suite 900NEW YORK, NY, United States 10016
- Phone
- 646-440-9333
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chief Executive Officer
- Sharon Mates
- President
- Michael Halstead
- Chief Financial Officer, Senior Vice President - Finance, Treasurer, Assistant Secretary
- Lawrence Hineline
- Executive Vice President, Chief Medical Officer
- Suresh Durgam
- Executive Vice President, Chief Commercial Officer
- Mark Neumann
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.2B |
|---|---|
Revenue (TTM) | $513.9M |
Shares Outstanding | 105.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.00 |
EPS | $-1.15 |
Book Value | $6.14 |
P/E Ratio | -57.8x |
Price/Sales (TTM) | 14.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -25.67% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
